BRI3BP anticorps (AA 188-251) (Cy7)
Aperçu rapide pour BRI3BP anticorps (AA 188-251) (Cy7) (ABIN668176)
Antigène
Voir toutes BRI3BP AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 188-251
-
Réactivité croisée
- Humain
-
Homologie
- Mouse,Rat,Dog,Cow,Chicken
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human BRI3BP
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- BRI3BP (BRI3 Binding Protein (BRI3BP))
-
Autre désignation
- BRI3BP
-
Sujet
-
Synonyms: KG19, BNAS1, HCCR-1, HCCR-2, HCCRBP-1, BRI3-binding protein, I3-binding protein, Cervical cancer 1 proto-oncogene-binding protein KG19, BRI3BP
Background: Involved in tumorigenesis and may function by stabilizing p53/TP53.
-
ID gène
- 140707
-
UniProt
- Q8WY22
Antigène
-